Global Continuous Renal Replacement Therapy Market
The global Continuous Renal Replacement Therapy Market is anticipated to reach $xx Mn in 2027 from
$xx Mn in 2020, at a CAGR of xx% during the forecast period.
Global Continuous Renal Replacement Therapy Market Overview & Dynamics:
Continuous renal replacement therapy (CRRT) is commonly used to provide renal support for critically ill
patients with acute kidney injury, particularly to patients who are hemodynamically unstable. Acute
kidney injury (AKI) is the sudden decrease in kidney function over a period of time, resulting in the
accumulation of creatinine, urea, and other waste products. It may be associated with the retention of
sodium and water and the development of metabolic disturbances, such as metabolic acidosis and
Rising incidences of diabetes and hypertension increase the risk of developing acute kidney injury (AKI),
which fuels the continuous Renal Replacement Therapy market. According to data published by WHO in
May 2019, 1.13 billion people are estimated to be suffering from hypertension, globally. The rise in
elevated blood pressure rates is likely to affect the patient population in low and middle-income
countries. Hypertension causes around 9.4 million deaths globally every year. It can affect AKI patients
and may result in acute renal failure. This factor is propelling the demand for CRRT systems.
Technological advances in the CRRT systems have resulted in a decline in mortality rate globally due to
increased effectiveness. An increase in the geriatric population, which is more prone to developing AKI is
anticipated to boost the market.
The report covers the detailed analysis of global Continuous Renal Replacement Therapy industry with
the classifications of the market based on modality, product type, therapy and end-users. Analysis of
past market dynamics from 2016 to 2019 is given in the report, which will help readers to benchmark
the past trends with current market scenarios with the key players c